Overview
The purpose of this research is to evaluate the effectiveness of a multidisciplinary pain management program for AIMSS in reducing pain, subjective cognitive complaints, psychological distress, and impaired functional status resulting in improved adherence to Aromatase Inhibitor medications compared to usual care. We want to identify predictors of improvement in pain, functional status, subjective cognition and mood following participation in the program.
Eligibility
Inclusion Criteria:
- At least 18 years old
- ECOG ≤ 2
- Stage 0-III HR+ breast cancer in need of strategies to reduce symptoms and improve quality of life
Exclusion Criteria:
• Less than 18 years of age.
- Stage 4 HR+ breast cancer